Vaccination with cell immunoglobulin mucin-1 antibodies and inactivated influenza enhances vaccine-specific lymphocyte proliferation, interferon-γ production and cross-strain reactivity: Vaccination using antigen plus TIM-1 mAbs enhances immunity to influenza antigens